
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Pathology, School of Medicine and 2 Department of Epidemiology, School of Public Health and Community Medicine, University of Washington; 3 Fred Hutchinson Cancer Research Center, Seattle, Washington; 4 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; and 5 Departments of Microbiology and Molecular Genetics, School of Medicine, University of New Mexico, Albuquerque, New Mexico
Requests for reprints: Long Fu Xi, University of Washington, 1914 North 34th Street, Suite 300, Seattle WA 98103. Phone: 206-616-9787; Fax: 206-616-9788. E-mail: longfu{at}u.washington.edu
Background: Although the variant lineages of human papillomavirus (HPV) types 16 and 18 are well established, their individual associations with high-grade cervical intraepithelial neoplasia (CIN) have not been extensively evaluated.
Methods: Study subjects were women participating in the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study who were positive for HPV16 or HPV18 at enrollment. These women were followed every 6 months for 2 years. Viral isolates from enrollment samples were characterized by DNA sequencing and classified as variant lineages.
Results: Over a 2-year study period, CIN3 was histologically diagnosed in 291 of the 779 HPV16-positive women and 47 of the 275 HPV18-positive women. Among women without CIN2-3 at enrollment, the risk of subsequent CIN3 was 2.7-fold greater for those with HPV16 African-2 [95% confidence interval (95% CI), 1.0-7.0] and 3.1-fold greater for those with HPV16 Asian American (95% CI, 1.6-6.0), compared with European variants. Relative to infection with HPV18 African variants, the risk associating subsequent CIN3 was 3.8 (95% CI, 0.9-17.2) for infection with HPV18 European variants and 4.8 (95% CI, 1.0-23.6) for infection with HPV18 Asian American variants. Similar associations were observed when the 2-year prevalence of CIN3 was used as the end point. Further, for those with HPV16 European variants, the 2-year prevalence of CIN3 was higher in White women than in African American women (P = 0.01); this trend was reversed for those with HPV16 African-1 variants (P = 0.22). A similar pattern was present for infections with HPV18 European versus African variants.
Conclusions: The lineages of HPV16 and HPV18 variants are associated with differing risks for high-grade CIN. (Cancer Epidemiol Biomarkers Prev 2007;16(1):410)
This article has been cited by other articles:
![]() |
Z. Chen, R. DeSalle, M. Schiffman, R. Herrero, and R. D. Burk Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97 J. Virol., February 1, 2009; 83(3): 1443 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jeronimo, N. Wentzensen, R. Long, M. Schiffman, S. T. Dunn, R. A. Allen, J. L. Walker, M. A. Gold, R. E. Zuna, M. E. Sherman, et al. Evaluation of Linear Array Human Papillomavirus Genotyping Using Automatic Optical Imaging Software J. Clin. Microbiol., August 1, 2008; 46(8): 2759 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, and F. M. Buonaguro Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women J. Gen. Virol., June 1, 2008; 89(6): 1380 - 1389. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |